Chief Financial Officer

Head of Research & Development/Chief Medical Officer

Syndax’s Revuforj® (revumenib) Included in NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for the Treatment of Relapsed or Refractory NPM1 Mutated Acute Myeloid Leukemia

Syndax's Revumenib Added to National Cancer Guidelines for NPM1-Mutant Acute Myeloid Leukemia

Syndax Gains Attention With Strong Drug Portfolio, Path To Leukemia Market Growth

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - September 5, 2025

Associate Director, Competitive and Market Insights

Syndax Pharmaceuticals is a commercial stage biopharmaceutical company developing an innovative pipeline of cancer therapies. They are seeking a strategic and experienced Insights leader to shape their pharmaceutical market research and competitive intelligence functions, critical for driving business decisions through actionable insights.

Director, Head of Compensation and Benefits

Talent Acquisition Partner | TSP Talent Solutions RPO

Head of Market Analytics and Insights,

Sign up with Google

Sign in with Google